StockTipsArenaBeta

BUY IPCA Laboratories Limited — ICICI Securities

BUYIPCA Laboratories Limited
IPCA Laboratories share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)17 Feb 2026via Institutional / Brokerage Research

Entry₹1,491.6Inferred
Target₹1,800
Total upside +20.68% (call closed)
Stop lossNot given
Exit₹1,8006 Jul 2026, 12:00 am
Target hit+20.68%0.00%upside left
Follow ICICI Securities for new calls(67% target hit, 1027 closed calls)Get alertsWatch IPCALAB for new buy/sell callsGet alertsSee 2 active Long-term calls on IPCALABSee 274 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 24 Oct, 2:55 am IST
4 supporting1 neutral0 opposing
Supports the BUY call (4)

IPCA Laboratories Limited's Board approved the Scheme of Amalgamation of Krebs Biochemicals & Industries Ltd. with Ipca Laboratories Ltd. The merger aims for operational synergies, cost optimization,

NSE · Outcome of Board Meeting·26 Jun · 1w ago

(opens in new tab)

IPCA Laboratories has entered a licensing agreement to access a proprietary biologics delivery platform for developing oncology and inflammatory disease treatments.

NSE · Press Release·12 Jun · 3w ago

(opens in new tab)

Ipca Laboratories has entered into a global licensing agreement with Bhami's Research Laboratory (BRL) for BRL's proprietary high-concentration subcutaneous biologics delivery platform. This collabora

BSE · Company Update·12 Jun · 3w ago

(opens in new tab)

1 other SEBI-registered advisor has an active long-term BUY call on this stock

Advisor consensus · same horizon·17 Mar · 4mo ago

Neutral / worth noting (1)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on IPCA Laboratories

All analyst calls on IPCA Laboratories

More from ICICI Securities

Every call and its outcome